One important biomarker indicative of the severity of liver dysfunction or Dysfunction-Associated Steatotic Liver Disease is paraoxonase, specifically the activity of the enzyme paraoxonase-1 (PON1) [5]. This evidence concerns the gene PON1 and Decreased liver function.